当前位置: 首页 > 期刊 > 《中国保健营养.中旬刊》 > 20137
编号:13724335
射频消融治疗失代偿肝硬化伴发肝细胞癌的效果和护理观察(2)
http://www.100md.com 2013年7月1日 《中国保健营养·中旬刊》 20137
     总之,本研究RFA对肝功能失代偿HCC具有良好的安全性和治疗效果,可延长生存期,是无法手术治疗的晚期HCC的治疗选择。治疗前做好心理护理及治疗准备;治疗中密切观察病情变化;治疗后加强腹部症状及尿量的观察,做好疼痛、生命体征的观察及护理,重视出院指导,可减少患者痛苦,提高生存质量。

    参考文献:

    [1] Trobaugh-Lotrario AD, Tomlinson GE, Finegold MJ, et al. Small cell undifferentiated variant of he patoblastoma: adverse clinical and molecular features similar to rhabdoid tumors. Pediatr Blood Cancer 2009;52: 328-34.

    [2] De Ioris M, Brugieres L , Zimmermann A, et al. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer 2008;44:545-50.

    [3] Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta,2006,371 (1-2) :1-12.

    [4] Kaneko A,Umaa V, Nakamura K, et al. Vitamin D receptor polymorphism among rickets children in Mongolia. J Epidemiol,2007, 17(1) :25-29.

    [5] The National Lung Screening Trial Research Team. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243-53., http://www.100md.com(胡栋娥)
上一页1 2